216
Participants
Start Date
March 22, 2021
Primary Completion Date
May 31, 2026
Study Completion Date
May 31, 2026
BMS-986158
Specified dose on specified days
Ruxolitinib
Specified dose on specified days
Fedratinib
Specified dose on specified days
Local Institution - 0075, Budapest
Local Institution - 0036, Blacktown
Local Institution - 0032, Wollongong
Local Institution - 0007, East Melbourne
Local Institution - 0006, Heidelberg
Local Institution - 0074, Debrecen
Local Institution - 0072, Nyíregyháza
Local Institution - 0015, West Perth
Local Institution - 0041, Nedlands
Local Institution - 0073, Szeged
Local Institution - 0061, Chaïdári
Local Institution - 0008, Marseille
Local Institution - 0049, Seongnam
Local Institution - 0042, Pittsburgh
Local Institution - 0050, Lübeck
Local Institution - 0002, Brescia
Local Institution - 0076, Chapel Hill
Local Institution - 0054, Madrid
Local Institution - 0026, Madrid
Local Institution - 0030, Brest
Local Institution - 0090, Lake Mary
Local Institution - 0021, Salamanca
Local Institution - 0012, Verona
Local Institution - 0029, Santander
Local Institution - 0003, Bologna
Local Institution - 0039, Essen
Local Institution - 0094, Valencia
Local Institution - 0033, Ann Arbor
Local Institution - 0001, Florence
Local Institution - 0043, New Orleans
Local Institution - 0011, Paris
Local Institution - 0068, Erding
Local Institution - 0069, Newport Beach
Local Institution - 0010, Villejuif
Local Institution - 0051, Cluj-Napoca
Local Institution - 0018, Petah Tikva
Local Institution - 0017, Ramat Gan
Local Institution - 0019, Tel Aviv
Local Institution - 0086, Beersheba
Local Institution - 0016, Jerusalem
Local Institution - 0038, Worcester
Local Institution - 0045, Hackensack
Local Institution - 0027, Nice
Local Institution - 0040, Chemnitz
Local Institution - 0035, Halle
Local Institution - 0047, Thessaloniki
Local Institution - 0077, Słupsk
Local Institution - 0062, Gdansk
Local Institution - 0052, Bucuresti
Local Institution - 0083, Bucharest
Local Institution - 0048, Seoul
Local Institution - 0053, Seoul
Local Institution - 0020, Badalona
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY